Known for cancer blockbusters, AstraZeneca is chasing the market built by Wegovy and Mounjaro with a weight loss drug of its own.
Recap by typeshit. Post by Facebook on Facebook.
Tara Wider has spent about five years posting on holistic beauty and women's wellness, building a following of women her age on social media.
Brown says diet and exercise still matter, but argues that shaming people for treating obesity with medication has never made anyone healthier.
A short share on growing GLP-1 use in the US, with no figures or sources attached. Thin on detail beyond the headline itself.
A new survey covered by Chain Store Age tracks how GLP-1 users are shifting their food spending from restaurants toward grocery stores.
He points out 7.9% quit the 12 mg dose over side effects versus 2.7% on Ozempic, a 5.2 point gap, and flags more skin sensation complaints.
The hosts point to rapid, significant weight loss as a known trigger for hair shedding, separate from the medication itself.
Loading…